Sigma Planning’s Lantern Pharma LTRN Stock Holding History
Bought
Maintained
Sold
Other funds holding LTRN
CM
Sigma Planning's LTRN Position: Q2 2025 in Review
Sigma Planning sold out of Lantern Pharma (LTRN) in Q2 2025, closing a stake of 28,650 shares — an estimated $101K sold.
Sigma Planning first reported a position in LTRN in Q4 2021 and held it in 14 quarters. The position peaked at $236K in Q1 2024. 37 funds tracked by Wall St. Rank hold LTRN as of Q2 2025.
- Sigma Planning reported no remaining Lantern Pharma position as of Q2 2025 after selling out during the quarter.
- Sigma Planning sold 28,650 Lantern Pharma shares in Q2 2025, an estimated $101K.
- Sigma Planning first reported a position in Lantern Pharma in Q4 2021 and held it in 14 quarters.
- Sigma Planning's Lantern Pharma position peaked at $236K in Q1 2024.
- 37 funds tracked by Wall St. Rank held Lantern Pharma as of Q2 2025.
Based on Sigma Planning's 13F filing for Q2 2025, filed 5 Aug 2025.